Navigation Links
Vantia Therapeutics' Pipeline Continues to Mature
Date:3/24/2009

SOUTHAMPTON, England, March 24 /PRNewswire/ --

- VA106483 Completes Phase IIa Trial and VA111913 Completes Phase I Dosing

Vantia Therapeutics, a company focusing on first-in-class therapies for unmet medical needs, announces further clinical trial progress with its two lead development compounds, VA106483 for nocturia associated with benign prostatic hypertrophy (BPH) and VA111913 for dysmenorrhoea. The Phase IIa trial of VA106483 has completed, while dosing is complete in the Phase I trial of VA111913. With this news and developments in Vantia's preclinical pipeline, the company is continuing to generate value from its extensive library of small molecule antagonists of hormones and proteases.

Following the completion of the 27-patient Phase IIa trial of VA106483, a vasopressin agonist, results are expected in H1 2009, with the Phase IIb study expected to start in the second half of the year. Up to 200 males with nocturia are expected to be involved in this dose-finding placebo-controlled study, which is expected to complete in the first half of 2010.

Given Vantia Therapeutics' strategy of developing products to the end of proof of concept/Phase IIb trials, the product is expected to be outlicensed for further development after the Phase IIb results. Nocturia in BPH is believed to represent a potential market in excess of $1bn, and VA106483's potential in follow-on indications such as overactive bladder and general nocturia could add significant extra value.

The Phase I trial for VA111913 has recruited the last of its 99 volunteers, and is also expected to report data in H1 2009. Phase IIa trials are expected to start in the second half of this year, involving over 100 patients and completing in H2 2010. VA111913 is a vasopressin antagonist, with dysmenorrhoea (painful menstruation) believed to represent a multibillion dollar market for which there is currently no t
'/>"/>

SOURCE Vantia Therapeutics
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
2. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
3. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
4. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
5. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
6. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
7. Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD
8. TorreyPines Therapeutics Initiates a Phase I Multiple Dose Clinical Trial of Tezampanel
9. TorreyPines Therapeutics Completes Phase I Multiple Dose Clinical Trial of NGX267, a Selective M1 Agonist for the Potential Treatment of Cognitive Impairment Associated with Schizophrenia
10. Cell Therapeutics, Inc. (CTI) Launches Phase III Study for Pixantrone in Relapsed Indolent Non-Hodgkins Lymphoma (NHL)
11. Cell Therapeutics, Inc. (CTI) Sponsors Panel Discussion on Women and Lung Cancer on Capitol Hill
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... -- Intercept Pharmaceuticals, Inc.  (NASDAQ: ICPT ), a ... commercialization of novel bile acid therapeutics to treat chronic ... public offering of 1,730,000 shares of its common stock ... In addition, Intercept has granted the underwriters a 30-day ... of common stock. All of the shares ...
(Date:6/18/2013)... 18, 2013  Actavis, Inc. (NYSE: ACT ) ... the U.S. Securities and Exchange Commission (SEC) a registration statement ... Warner Chilcott plc (NASDAQ: WCRX ), ... Warner Chilcott (the "Form S-4"). As previously ... have entered into a definitive agreement pursuant to which ...
(Date:6/18/2013)... , June 18, 2013  Recent regulatory and ... for Medical Education groups at large pharmaceutical companies to ... safe and effective use of their new products. With ... industry, it is crucial that these "Med Ed" ... professionals. To address the changes that are ...
Breaking Medicine Technology:Intercept Pharmaceuticals Announces Pricing of Public Offering of Common Stock 2Actavis Files Registration Statement on Form S-4 in Connection with Proposed Warner Chilcott Acquisition 2Actavis Files Registration Statement on Form S-4 in Connection with Proposed Warner Chilcott Acquisition 3Actavis Files Registration Statement on Form S-4 in Connection with Proposed Warner Chilcott Acquisition 4Actavis Files Registration Statement on Form S-4 in Connection with Proposed Warner Chilcott Acquisition 5Actavis Files Registration Statement on Form S-4 in Connection with Proposed Warner Chilcott Acquisition 6Actavis Files Registration Statement on Form S-4 in Connection with Proposed Warner Chilcott Acquisition 7Though Vital to Educating Doctors on New Products, Pharma "Med Ed" Groups Working Under Huge Internal & External Constraints 2
... Muscular Dystrophy Association ( MDA ) has awarded $750,000 to ... development of an experimental drug that may become a viable ... The funding comes from MDA Venture Philanthropy (MVP), ... is one of nine types of muscular dystrophy, a group ...
... panel of experts has recommended changes to the guidelines ... suffering from severe chronic pain. The 2011 Polyanalgesic Consensus ... in chronic pain management for the purpose of updating ... improving the technical quality of care in chronic pain. ...
Cached Medicine Technology:MDA Awards $750,000 to Help Summit Test New Drug Formulation in Phase 1 Clinical Trial of Potential Treatment for Duchenne Muscular Dystrophy 2MDA Awards $750,000 to Help Summit Test New Drug Formulation in Phase 1 Clinical Trial of Potential Treatment for Duchenne Muscular Dystrophy 3MDA Awards $750,000 to Help Summit Test New Drug Formulation in Phase 1 Clinical Trial of Potential Treatment for Duchenne Muscular Dystrophy 42011 Consensus Panel Issues New Guidelines for Intrathecal Pain Management 22011 Consensus Panel Issues New Guidelines for Intrathecal Pain Management 32011 Consensus Panel Issues New Guidelines for Intrathecal Pain Management 42011 Consensus Panel Issues New Guidelines for Intrathecal Pain Management 52011 Consensus Panel Issues New Guidelines for Intrathecal Pain Management 6
(Date:6/19/2013)... Sudden cardiac arrest can strike anyone, even a child, ... 5 minutes after cardiac arrest, but the average emergency medical ... death is highly probable if an automated external defibrillator or ... response to this dire reality, US Representative Lois Capps (CA-24) ... 2308) which would provide support for AED and CPR training ...
(Date:6/19/2013)... Middletown, NJ (PRWEB) June 19, 2013 Anant ... is changing and changing rapidly. The first industrial revolution began ... of the textile industry… when the factory was born. The ... Henry Ford mastered the moving assembly line and ushered in ... under way in the 21st century. Manufacturing is going digital ...
(Date:6/19/2013)... (PRWEB) June 19, 2013 Indosoft ... Center ACD for Asterisk, announced today the ... 5.7. This enhancement offers improved options for extracting, ... dashboards for effective contact center management. , Large ... real-time captured as it happens from the call ...
(Date:6/19/2013)... June 19, 2013 CoachingWebsites, ... for coaches, announced today its affiliation with ... will offer exclusive websites and marketing solutions and ... “This new partnership with Active Intelligence shows our ... to its fullest,” says Greer Van Dyck, Online ...
(Date:6/19/2013)... The Mesothelioma Victims Center says, "According to ... 3000 citizens, who will be diagnosed with a rare ... third will be US Navy Veterans. We can assure ... form of cancer, or their family members that we ... skilled mesothelioma compensation settlement attorneys, who actually do have ...
Breaking Medicine News(10 mins):Health News:AED.com Supports Automated External Defibrillator (AED) Legislation in Schools in US and UK 2Health News:RKNet Studios Announced Cognitions Bridge Intelligence Games for Fun, Cognitive Skills Testing and Development for Success in Life 2Health News:RKNet Studios Announced Cognitions Bridge Intelligence Games for Fun, Cognitive Skills Testing and Development for Success in Life 3Health News:RKNet Studios Announced Cognitions Bridge Intelligence Games for Fun, Cognitive Skills Testing and Development for Success in Life 4Health News:Indosoft Improves Q-Suite Real-time ACD Reporting to Enhance Contact Center Productivity 2Health News:CoachingWebsites (Websites for Coaches) Announces Their Partnership With Active Intelligence, LLC 2Health News:Mesothelioma Victims Center Urges US Navy Veterans Diagnosed With Mesothelioma To Call Them For Instant Access To The Nation's Top Asbestos Lawyers-Better Compensation 2Health News:Mesothelioma Victims Center Urges US Navy Veterans Diagnosed With Mesothelioma To Call Them For Instant Access To The Nation's Top Asbestos Lawyers-Better Compensation 3
... Some patients with advanced nonsmall-cell lung cancer (NSCLC) have ... drug cisplatin than another platinum-based drug carboplatin, according ... the National Cancer Institute. The authors conclude that cisplatin ... patients. ,Most clinicians in North America prefer ...
... likely to have elevated markers of inflammation, called inflammatory ... distinguished the men with low testosterone was a ... and diabetes risk factors related to this type of ... more likely to have the metabolic syndrome than men ...
... 2002, fifteen months after the 9/11 terrorist attacks, President George ... Eisenhower Executive Office Building next door to the White ... in laboratories, and we believe that regimes hostile to the ... information that a smallpox attack is imminent. Yet it is ...
... According to a study in the June 6 issue of ... of colorectal tumors. Some previous studies have suggested that ... ,Bernard F. Cole, Ph.D., of Dartmouth Medical School, Hanover, ... prevention of new colorectal adenomas in persons with a history ...
... like some phantasy. They live longer than almost anyone in ... vaccinated, and such scourges of the poor as parasites, ... see a doctor, at low cost, right in the neighborhood. ... indeed stupendous. The recent Michael Moore documentary pouring scorn on ...
... make some of us gain more weight than others- ... molecule called BSX, as scientists from the European ... Nutrition [DIFE], Potsdam, and the University of Cincinnati report ... ,Bsx is the molecular link between spontaneous physical activity ...
Cached Medicine News:Health News:Low Levels of Testosterone may Increase the Risk of Death in Older Men 2Health News:Low Levels of Testosterone may Increase the Risk of Death in Older Men 3Health News:New Smallpox Vaccine Contract: Five Years in the Making 2Health News:The Risk of Colorectal Tumor is Not Reduced With Folic Acid Supplements 2Health News:Cuba is Exporting Healthcare Now 2Health News:Cuba is Exporting Healthcare Now 3Health News:Cuba is Exporting Healthcare Now 4Health News:Cuba is Exporting Healthcare Now 5Health News:Molecular Basis of Obesity-Revealing the Unknown Facts 2
... Medline Has the Right Solution For ... tracheostomy clean and care tray features the ... of this important infection control task. Designed ... the individual needs of each patient and ...
... the Right Solution For Your Tracheostomy Care ... care tray features the latest components for ... infection control task. Designed by clinicians, these ... of each patient and caregiver. All of ...
... alternate care facilities with a wide ... offer the finest in nursing convenience ... guidance of experienced nursing personnel, these ... is required for efficient and quick ...
... Kendall provides hospitals and alternate ... of tracheostomy care trays which offer ... infection control. Designed with the guidance ... total-care trays provide exactly what is ...
Medicine Products: